Frontlight ResearchEarly access
Trial site
Tokyo Medical and Dental University Hospital
- 9running trials
- 4closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis3 trials
- Crohn's disease2 trials
- Atrial fibrillation1 trial
- Bladder cancer1 trial
- Chronic lymphocytic leukaemia1 trial
- Head and neck cancer1 trial
- Hepatitis B1 trial
- Lupus (SLE)1 trial
- Myeloproliferative neoplasms1 trial
- Prostate cancer1 trial
- Phase
- Phase 36 trials
- Phase 24 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting8 trials
- Completed4 trials
- Recruiting1 trial
- Lead sponsor
- Janssen Research & Development, LLC7 trials
- Abivax S.A.1 trial
- Biogen1 trial
- Incyte Corporation1 trial
- Janssen Pharmaceutical K.K.1 trial
- and 2 more
Running trials
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Recruiting
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Head and neck cancer1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026